Lefèvre J P, Björnsson E, Johansson L. "一种卡巴拉汀 RC 5的合成方法" [P]. European Patent, EP 3387242 A1, 2015-10-27.
发明人王建平,韩伟,朱建伟. "Method for the Synthesis of Rivastigmine RC 5" [P]. 中国发明专利, 专利号 CN 112472358 B, 授权公告日 2025-08-01.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of 卡巴拉汀 RC 5 in Pharmaceutical Formulations". Anal. Chim. Acta, 2017, 2477, (8), 3848-3854.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 卡巴拉汀 RC 5 as an Impurity". Phytochemistry, 2023, 1520, (3), 8333-8358.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of Rivastigmine RC 5 Using HRMS and NMR". Food Chem., 2022, 1293, (9), 7886-7909.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate 卡巴拉汀 RC 5 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2021, 1263, 5069-5090.